Cargando…

Pruritogenic molecules in the skin of patients with dermatomyositis

INTRODUCTION: Pruritus is a common excruciating symptom in systemic autoimmune diseases such as dermatomyositis (DM) but the pathogenesis is not fully understood. We intended to investigate the targeted expression analysis of candidate molecules involved in the development of pruritus in lesional vs...

Descripción completa

Detalles Bibliográficos
Autores principales: Vincze, Anett, Herczeg-Lisztes, Erika, Szabó, Katalin, Béldi, Tibor Gábor, Nagy-Vincze, Melinda, Pór, Ágnes, Varga, József, Dankó, Katalin, Biró, Tamás, Tóth, Balázs István, Griger, Zoltán
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213747/
https://www.ncbi.nlm.nih.gov/pubmed/37250649
http://dx.doi.org/10.3389/fmed.2023.1168359
_version_ 1785047693456834560
author Vincze, Anett
Herczeg-Lisztes, Erika
Szabó, Katalin
Béldi, Tibor Gábor
Nagy-Vincze, Melinda
Pór, Ágnes
Varga, József
Dankó, Katalin
Biró, Tamás
Tóth, Balázs István
Griger, Zoltán
author_facet Vincze, Anett
Herczeg-Lisztes, Erika
Szabó, Katalin
Béldi, Tibor Gábor
Nagy-Vincze, Melinda
Pór, Ágnes
Varga, József
Dankó, Katalin
Biró, Tamás
Tóth, Balázs István
Griger, Zoltán
author_sort Vincze, Anett
collection PubMed
description INTRODUCTION: Pruritus is a common excruciating symptom in systemic autoimmune diseases such as dermatomyositis (DM) but the pathogenesis is not fully understood. We intended to investigate the targeted expression analysis of candidate molecules involved in the development of pruritus in lesional vs. non-lesional skin samples of patients affected with active DM. We looked for correlations between the investigated pruriceptive signaling molecules, disease activity, and itching sensation of DM patients. METHODS: Interleukins (IL-33 and IL-6), tumor necrosis factor α (TNF-α), peroxisome proliferator-activated receptor γ (PPAR-γ), and ion channels belonging to the transient receptor potential (TRP) family were analyzed. The expression of TNF-α, PPAR-γ, IL-33, IL-6, and TRP channels in lesional DM skin was evaluated by RT-qPCR and immunohistochemistry and was compared with non-lesional DM skin samples. Pruritus, disease activity, and damage of DM were evaluated by the 5-D itch scale and Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), respectively. Statistical analysis was performed with IBM SPSS 28 software. RESULTS: A total of 17 active DM patients participated in the study. We could show that the itching score was positively correlated with the CDASI activity score (Kendall's tau-b = 0.571; p = 0.003). TNF-α gene expression was significantly higher in lesional DM skin than in non-lesional DM skin (p = 0.009) and differed in the subgroups of patients with different itch intensities (p = 0.038). The mRNA expression of lesional IL-6 correlated positively with 5-D itch and CDASI activity score (Kendall's tau-b = 0.585; p = 0.008 and 0.45; p = 0.013, respectively). TRPV4 expressions were positively correlated with CDASI damage score (Kendall's tau-b = 0.626; p < 0.001), but the mRNA expressions of the TRP family, PPAR-γ, IL-6, and IL-33 were not different in lesional and non-lesional samples. Immunohistochemistry analysis did not find significant alterations in the expressions of TNF-α, PPAR-γ, IL-6, and IL-33 in lesional and non-lesional regions. DISCUSSION: Our results argue that cutaneous disease activity, TNF-α, and IL-6 might play a central role in DM-associated itch, while TRPV4 plays a central role in tissue regeneration.
format Online
Article
Text
id pubmed-10213747
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-102137472023-05-27 Pruritogenic molecules in the skin of patients with dermatomyositis Vincze, Anett Herczeg-Lisztes, Erika Szabó, Katalin Béldi, Tibor Gábor Nagy-Vincze, Melinda Pór, Ágnes Varga, József Dankó, Katalin Biró, Tamás Tóth, Balázs István Griger, Zoltán Front Med (Lausanne) Medicine INTRODUCTION: Pruritus is a common excruciating symptom in systemic autoimmune diseases such as dermatomyositis (DM) but the pathogenesis is not fully understood. We intended to investigate the targeted expression analysis of candidate molecules involved in the development of pruritus in lesional vs. non-lesional skin samples of patients affected with active DM. We looked for correlations between the investigated pruriceptive signaling molecules, disease activity, and itching sensation of DM patients. METHODS: Interleukins (IL-33 and IL-6), tumor necrosis factor α (TNF-α), peroxisome proliferator-activated receptor γ (PPAR-γ), and ion channels belonging to the transient receptor potential (TRP) family were analyzed. The expression of TNF-α, PPAR-γ, IL-33, IL-6, and TRP channels in lesional DM skin was evaluated by RT-qPCR and immunohistochemistry and was compared with non-lesional DM skin samples. Pruritus, disease activity, and damage of DM were evaluated by the 5-D itch scale and Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), respectively. Statistical analysis was performed with IBM SPSS 28 software. RESULTS: A total of 17 active DM patients participated in the study. We could show that the itching score was positively correlated with the CDASI activity score (Kendall's tau-b = 0.571; p = 0.003). TNF-α gene expression was significantly higher in lesional DM skin than in non-lesional DM skin (p = 0.009) and differed in the subgroups of patients with different itch intensities (p = 0.038). The mRNA expression of lesional IL-6 correlated positively with 5-D itch and CDASI activity score (Kendall's tau-b = 0.585; p = 0.008 and 0.45; p = 0.013, respectively). TRPV4 expressions were positively correlated with CDASI damage score (Kendall's tau-b = 0.626; p < 0.001), but the mRNA expressions of the TRP family, PPAR-γ, IL-6, and IL-33 were not different in lesional and non-lesional samples. Immunohistochemistry analysis did not find significant alterations in the expressions of TNF-α, PPAR-γ, IL-6, and IL-33 in lesional and non-lesional regions. DISCUSSION: Our results argue that cutaneous disease activity, TNF-α, and IL-6 might play a central role in DM-associated itch, while TRPV4 plays a central role in tissue regeneration. Frontiers Media S.A. 2023-05-11 /pmc/articles/PMC10213747/ /pubmed/37250649 http://dx.doi.org/10.3389/fmed.2023.1168359 Text en Copyright © 2023 Vincze, Herczeg-Lisztes, Szabó, Béldi, Nagy-Vincze, Pór, Varga, Dankó, Biró, Tóth and Griger. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Vincze, Anett
Herczeg-Lisztes, Erika
Szabó, Katalin
Béldi, Tibor Gábor
Nagy-Vincze, Melinda
Pór, Ágnes
Varga, József
Dankó, Katalin
Biró, Tamás
Tóth, Balázs István
Griger, Zoltán
Pruritogenic molecules in the skin of patients with dermatomyositis
title Pruritogenic molecules in the skin of patients with dermatomyositis
title_full Pruritogenic molecules in the skin of patients with dermatomyositis
title_fullStr Pruritogenic molecules in the skin of patients with dermatomyositis
title_full_unstemmed Pruritogenic molecules in the skin of patients with dermatomyositis
title_short Pruritogenic molecules in the skin of patients with dermatomyositis
title_sort pruritogenic molecules in the skin of patients with dermatomyositis
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213747/
https://www.ncbi.nlm.nih.gov/pubmed/37250649
http://dx.doi.org/10.3389/fmed.2023.1168359
work_keys_str_mv AT vinczeanett pruritogenicmoleculesintheskinofpatientswithdermatomyositis
AT herczegliszteserika pruritogenicmoleculesintheskinofpatientswithdermatomyositis
AT szabokatalin pruritogenicmoleculesintheskinofpatientswithdermatomyositis
AT belditiborgabor pruritogenicmoleculesintheskinofpatientswithdermatomyositis
AT nagyvinczemelinda pruritogenicmoleculesintheskinofpatientswithdermatomyositis
AT poragnes pruritogenicmoleculesintheskinofpatientswithdermatomyositis
AT vargajozsef pruritogenicmoleculesintheskinofpatientswithdermatomyositis
AT dankokatalin pruritogenicmoleculesintheskinofpatientswithdermatomyositis
AT birotamas pruritogenicmoleculesintheskinofpatientswithdermatomyositis
AT tothbalazsistvan pruritogenicmoleculesintheskinofpatientswithdermatomyositis
AT grigerzoltan pruritogenicmoleculesintheskinofpatientswithdermatomyositis